Publications

Relevant Publications

Donor characteristics may contribute to platelet variability

Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility. Transfusion. 2003; 43: 328-334.

Economic Impact of Donor Platelet Count and Platelet Yield in Apheresis Products: Relevance for emerging Issues in Platelet Transfusion Therapy. Vox Sang. 1999; 76: 43-49.

High incidence of defective high-shear platelet function among platelet donors. Transfusion. 2004; 44: 764-770.

Platelet function abnormalities in qualified whole-blood donors: effects of medication and recent food intake. Vox Sang. 2004; 86: 48-53.

 

Microparticles and clinical implications

Formation and fate of platelet microparticles. Blood Cell Mol Dis. 2006; 36: 181-187.

Cell Membrane Microparticles in Blood and Blood Products: Potentially Pathogenic Agents and Diagnostic Markers. Transfusion Med Rev. 2006; 20: 1-26.

Cellular microparticles: new players in the field of vascular disease? Euro J Clin Invest. 2004; 34: 392-401.

Circulating microparticles: pathophysiology and clinical implications. Blood Rev. 2007;21: 157-171.

Clinical relevance of microparticles from platelets and megakaryocytes. Current Opin Hematol. 2010; 17: 578-584.

Function and role of microparticles in various clinical settings. Thromb Res. 2008; 123: 8-23.

Cell-Derived Microparticles in the Pathogenesis of Cardiovascular Disease. Arterioscler Thromb Vasc Biol. 2011; 31: 4-9.

 

Testing platelets for transfusion medicine

Storage and Quality Assessment of Platelets. Vox Sang. 1998; 74 (Supple. 2): 207-216

Correlation of ­in vitro­ platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang. 2006; 90: 279-285.

In vitro assays used in the evaluation of the quality of stored platelets: Correlation with in vivo assays. Transfus Apher Sci. 2008; 39: 161-165.

High-yield platelet concentrates attainable by continuous quality improvement reduce platelet transfusion cost and donor exposure. Transfusion. 1997; 37: 482-486.

Development of a quality monitoring program for platelet components: a report of the first four years’ experience at Canadian Blood Services. Transfusion. 2012; 52: 810- 818.

Methods for testing platelet function for transfusion medicine. Vox Sang. 2011; 101: 1-9.

Quantity without quality? Don’t dismiss the value of platelet function testing quite yet. Minerva Anestesiologica. 2012; 78: 519-520

Platelet Transfusions: Utilization and Associated Costs in a Tertiary Care Hospital. Am J Hematol. 2000; 64: 251-256.

Clinical and Blood Bank Factors in the Management of Platelet Refractoriness and Alloimmunization. Blood. 1993; 81:3428-3434

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood. 2005;105: 4106-4114.